Market open
Quanterix/$QTRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Quanterix
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Ticker
$QTRX
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
471
ISIN
US74766Q1013
Website
Quanterix Metrics
BasicAdvanced
$166M
-
-$1.24
1.11
-
Price and volume
Market cap
$166M
Beta
1.11
52-week high
$19.18
52-week low
$4.05
Average daily volume
808K
Financial strength
Current ratio
8.293
Quick ratio
7.306
Long term debt to equity
9.946
Total debt to equity
11.507
Management effectiveness
Return on assets (TTM)
-9.38%
Return on equity (TTM)
-14.51%
Valuation
Price to revenue (TTM)
1.215
Price to book
0.52
Price to tangible book (TTM)
0.56
Price to free cash flow (TTM)
-4.994
Growth
Revenue change (TTM)
7.71%
Earnings per share change (TTM)
45.69%
3-year revenue growth (CAGR)
6.32%
3-year earnings per share growth (CAGR)
-11.55%
What the Analysts think about Quanterix
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Quanterix stock.
Quanterix Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Quanterix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Quanterix News
AllArticlesVideos
Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 days ago
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
Business Wire·1 week ago
Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Quanterix stock?
Quanterix (QTRX) has a market cap of $166M as of May 15, 2025.
What is the P/E ratio for Quanterix stock?
The price to earnings (P/E) ratio for Quanterix (QTRX) stock is 0 as of May 15, 2025.
Does Quanterix stock pay dividends?
No, Quanterix (QTRX) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next Quanterix dividend payment date?
Quanterix (QTRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Quanterix?
Quanterix (QTRX) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.